ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly taltz — Worldwide revenue ($M) [Q1–Q3 10-Q & FY through FY2024] ($M)
Form 10-Q MD&A & Form 10-K through FY2024
Latest, FY2024
3,260
Period ended Dec 31, 2024
Change on a year earlier
+18.1%
2,760 in FY2023
History
9 years
Since FY2016
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Taltz — Worldwide revenue ($M) [Q1–Q3 10-Q & FY through FY2024] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 3,260 | +18.1% | Form 10-K FY2024 (filed 2025-02-19) ↗ |
| FY2023 | Dec 31, 2023 | 2,760 | +11.2% | Form 10-K FY2023 (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 2,482 | +12.2% | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 2,213 | +23.7% | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 1,789 | +90.8% | Form 10-K FY2020 (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 938 | +67.7% | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 559 | 0.0% | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 559 | +394.4% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 113 | – | Form 10-K (filed 2018-02-20) ↗ |
Cite this data
StockData. (2026). Eli Lilly Taltz — Worldwide revenue ($M) [Q1–Q3 10-Q & FY through FY2024] ($M), annual FY2016–FY2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med_taltz_ww
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.